VS
Vikas Singh
About Vikas Singh
Data last updated:
Vikas Singh has 5 years in corporate governance. Holds Director role. Currently with 3 companies, including Waylone Healthcare Private Limited and Virexa Drugs Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Waylone Healthcare Private Limited at ₹2.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Mar 2021 | 2021 | ₹2.25 Cr (FY 2024) | Active | |
| Director | 06 Jun 2025 | 2025 | – | Active | |
| Director | 22 Apr 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikas Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikas Singh
Vikas Singh has 5 years in corporate governance. Holds Director role. Currently with 3 companies, including Waylone Healthcare Private Limited and Virexa Drugs Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Waylone Healthcare Private Limited at ₹2.25 Cr (FY 2024).
Vikas Singh is associated with 3 companies as Director, including Waylone Healthcare Private Limited (₹2.25 Cr), Virexa Drugs Private Limited, Edwell Pharmaceuticals Private Limited.
Vikas Singh has expertise in Healthcare, General Business.
Vikas Singh has 5 years in corporate governance.
By reported revenue, the largest current company of Vikas Singh is Waylone Healthcare Private Limited, with revenue of ₹2.25 Cr (FY 2024).
Vikas Singh currently holds positions at 3 companies: Waylone Healthcare Private Limited (₹2.25 Cr), Virexa Drugs Private Limited, Edwell Pharmaceuticals Private Limited.